Hamburg

• Study to determine the dose and safety of asciminib in pediatric patients with chronic myeloid leukemia. Recruiting
  2023-508129-28-00 9 2022-09-28 Pediatric patients with Philadelphia chromosome positive chronic myelo
• A multicenter, double-blind, randomized study to evaluate the effects of tasimelteon vs. placebo in participants with Delayed Sleep-Wake Pha … Recruiting
  2024-516962-13-00 5 2022-09-23 Delayed Sleep-Wake Phase Disorder (DSWPD)
• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia … Recruiting
  2023-510384-36-00 5 2022-09-13 Newly Diagnosed Multiple Myeloma
• A Phase 1b/2, Open-Label Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants with Advanced or … Recruiting
  2023-506517-22-00 9 2022-08-31 Advanced or Metastatic Colorectal Cancer
• Asciminib Roll-over Study Recruiting
  2023-507557-16-00 5 2022-08-31 chronic myelogenous leukemia (CML) or Philadelphia Chromosome positive
• Early Stage Follicular LymphOma and RadioTherapy PLUS anti-CD20 Antibody Recruiting
  2023-509278-41-00 5 2022-07-04 Early Stage Follicular LymphOma
• International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting
  2022-501180-40-00 5 2022-06-17 Ewing Sarcoma
• RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials (MMRd-GREEN) Recruiting
  2023-503267-42-00 5 2022-06-10 Patients with a histological diagnosis of mismatch- repair deficient h
• A clinical study to learn about the safety and effects of KIN-2787, a new oral anticancer drug for the treatment of patients with BRAF and/o … Recruiting
  2024-516331-27-00 3 2022-06-10 Participants with BRAF and/or NRAS mutation positive tumors
• Brigatinib in pediatric and young adult patients with ALK+ ALCL, IMT or other solid tumors (Briga-PED) Recruiting
  2024-513412-10-00 9 2022-05-11 Anaplastic Large Cell Lymphoma (ALCL)
• Window-of-opportunity proof-of-concept, non-randomized, open-label phase II trial of Olaparib given alone (cohort A) or in combination with … Recruiting
  2024-511780-28-00 4 2022-05-05 Patients with presumed and previously untreated advanced stage ovarian
• A non blinded phase-II study with 3 randomized patient groups of individualized suppression of the patient's immune system with donor modifi … Recruiting
  2024-513446-12-00 4 2022-05-03 Living donor kidney transplantation
• Clinical trial evaluating the safety, tolerability, and preliminary efficacy of BNT116 alone and in combinations in patients with advanced n … Recruiting
  2023-509283-14-00 1 2022-04-25 Advanced non-small cell lung cancer
• Randomised phase III trial of ADT +/- darolutamide in frail men with castration-naïve de novo metastatic prostate cancer Recruiting
  2022-502425-18-00 5 2022-04-19 Adenocarcinoma of the prostate
• A randomised controlled trial in preterm infants comparing prophylactic with selective “Less Invasive Surfactant Administration” (pro.LISA) Recruiting
  2024-516504-42-00 5 2022-03-05 Respiratory distress syndrome in preterm infants
• Study of HM15912 in subjects with Short Bowel Syndrome-associated Intestinal Failure Recruiting
  2024-515160-32-00 4 2022-02-02 Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting
  2023-505438-85-00 5 2022-01-12 Acute myocardial infarction (AMI)
• Safety, efficacy and pharmacokinetics of sparsentan in pediatric subjects with selected kidney diseases. Recruiting
  2023-505497-14-00 4 2021-12-09 Proteinuric glomerular diseases including: •Focal segmental glomerulo
• Post-resection/ ablation chemotherapy in patients with metastatic colorectal cancer (FIRE-9 - PORT / AIO-KRK-0418). Prospective, randomized, … Recruiting
  2024-512174-10-00 5 2021-11-11 metastatic colorectal cancer
• SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting
  2024-510578-25-00 5 2021-11-05 Histologically proven high-risk medulloblastoma, with any of the curre
• HARBOR: Study of BLU-263 for Indolent Systemic Mastocytosis Recruiting
  2024-516728-32-00 10 2021-10-29 Indolent Systemic Mastocytosis and SSM
• A Phase 1/2a, First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of HDP-101 in Patients with Plasma C … Recruiting
  2024-515273-10-00 7 2021-10-19 Relapsed or refractory Multiple Myeloma (r/r MM)
• A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients with Metastatic Colorectal Cancer (INTRINSIC) Recruiting
  2023-505163-37-00 3 2021-10-01 Metastatic Colorectal Cancer
• OPTIMISE Recruiting
  2023-509814-12-00 4 2021-09-22 Colorectal cancer with metastasis

Showing 481–504 of 1,087 trials